
Shorter TB Regimen Matched Standard Care in Rifampicin-Resistant Disease
A 6-month tuberculosis (TB) treatment regimen delivered similar results to the longer standard-of-care regimen in patients with pulmonary rifampicin-resistant TB, a phase III noninferiority trial showed. Among 402 pat...


